It is established that patients with testicular seminomas have a better prognosis than those with malignant teratomas or neoplasms containing both elements (Pugh, 1976) . The teratomatous element in a combined neoplasm may include extra-embryonic elements in addition to somatic and undifferentiated tumour tissue. However, when solitary giant cells morphologically resembling those in the syncytiotrophoblastic layer of the placenta (Figure la) are found in seminomas it has not been customary to classify these neoplasms as combined tumours. There are two reasons for this apparent paradox. Firstly, it was not certain that all giant cells were trophoblastic in origin, as various morphological forms of multinucleate cells can be found in seminomas including the tumour giant or "mulberry" cell (Thackray & Crane, 1976) (Figure 2a ) and the Langhans' giant cells ( Figure 3 ) associated with granulomata. Secondly, seminomas with giant cells did not appear to pursue a more malignant course and thus did not constitute a subgroup within a prognostic classification (Thackray & Crane, 1976; Peckham, 1981) .
Since the advent of the immunoperoxidase technique it has been possible-to localise human chorionic gonadotrophin (HCG) in wax-embedded tissue (Heyderman & Neville, 1976) (Thackray & Crane, 1976) .
The relationship between survival and the presence of HCG-containing cells was analysed only in P1 and P2 tumours, which had 3 year survival rates of 93 and 92% respectively and were thus considered to constitute a single prognostic group, whereas P3 tumours had a 3 year survival rate of 80% (Thackray & Crane, 1976 Table I . Sampling error was difficult to exclude, but the incidence was not related to the number of blocks examined (Table II) .
The relationship between the presence of HCGcontaining cells and survival in P1 and P2 tumours (13) syncytiotrophoblasts are an established morphological feature of some seminomas, the first description being attributed to Chevassu in 1906 P= 0.08. (Hedinger et al., 1979) , but their definition and incidence in different series have varied (Friedman & Moore, 1946; Dixon & Moore, 1952; Friedman & Pearlman, 1970; Mostofi & Price, 1973; Thackray & Crane, 1976) . Some studies include all giant cells except the Langhans cell, whereas others confined themselves to the typical syncytiotropho- showing the morphological features of syncytiotrophoblasts (Javadpour et al., 1978; Kurman et al., 1979; Mostofi, 1980) , or to be localised commonly in these cells and occasionally seen in seminoma In giant cells ("mulberry" cells) (Heyderman, 1978; Bosman et al., 1980) and rarely in "ordinary lization of HCG in some seminomas has seminoma cells" (Morgan et al., 1982) . )ns for their histological classification and
In agreement with previous workers (Heyderman, ,ourse. Incidence This is the first large series in which the incidence of HCG-containing cells in seminomas is described, the only other comparable series being that of Bosman et al. (1980) , who found an incidence of 3/46 (7%). In other publications it is not clear whether all seminomas have been investigated immunocytochemically or whether this technique has been restricted to those tumours in which syncytiotrophoblasts have been seen on H & E stained sections (Hedinger et al., 1979) or those associated with elevated serum levels of HCG (Javadpour et al., 1978) .
In 228 seminomas 14.5% were found to contain HCG positive cells. This figure is within the range of published data based on morphological appearances or HCG production. Since, as shown in Table II (Javadpour et al., 1978; Hedinger et al., 1979; Mostofi, 1980; Bosman et al., 1980 (Dixon & Moore, 1952; Wilson & Woodhead, 1972; Maier & Sulak, 1973 (Cochran et al., 1975; Bartsch et al., 1979; Javadpour, 1980 Javadpour, , 1983 but there is still no concensus as to its prognostic significance. Lange et al. (1980) suggest that this finding in association with metastatic seminoma is a poor prognostic sign and indicates the use of chemotherapy. A further clinical concern is that elevated HCG associated with seminoma might be related to classical trophoblastic tumour or choriocarcinoma missed by the sampling for histopathology.
The classification of tumours containing syncytiotrophoblasts as seminomas rather than combined tumours is inconsistent, as such cells constitute a teratomatous element. In addition, the natural history of seminomas with HCG-containing cells in this historical study was in two respects similar to that of combined tumours. Firstly, 23% of the patients with HCG-containing tumours were dead of their disease within 2 years of orchidectomy, compared with only 8% of the patients with tumours lacking this feature (P<0.01). Secondly, late relapse was not observed in the HCG-positive group, whereas 8/22 of the HCGnegative group died of their disease during the period 2-10 years following orchidectomy. In contrast to seminomas, late relapse is rarely encountered with teratomas. The clinical implication of these data is that seminomas containing HCG-positive cells might benefit more from treatment regimes used for non-seminomatous testicular germ cell tumours than those used for seminomas.
We wish to thank Professor K. Bagshawe for providing the HCG antiserum. The cases reviewed here were obtained from the British Testicular Tumour Registry.
